Aaron Ciner
University of Maryland, Baltimore
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Aaron Ciner as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:46 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT04098081 · 1911GCCC: Galeterone With Gemcitabine for Patients With Metastatic Pancreatic AdenocarcinomaUniversity of Maryland, Baltimore · active not recruiting · Advanced Pancreatic Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:46 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:46 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- Fate and function of hepatitis-C-virus-specific T-cells during peginterferon-alpha2b therapy for acute hepatitis C.Antivir Ther · 200720 citationsRCR 0.4
- A phase I study of the ceramide nanoliposome in patients with advanced solid tumors.Cancer Chemother Pharmacol · 202416 citationsRCR 2.7
- CD45/CD11b positive subsets of adult lung anchorage-independent cells harness epithelial stem cells in culture.J Tissue Eng Regen Med · 20134 citationsRCR 0.1
- Therapeutic alliance during trauma focused treatment in adolescent and young adult patients with PTSD.BMC Psychiatry · 20252 citationsRCR 1.9